Skip to main content
. 2018 Sep 10;20(4):213–219. doi: 10.14744/AnatolJCardiol.2018.65983

Table 2.

2D and Doppler echocardiographic parameters for the subjects

Parameters Levodopa (n=36) Levodopa+pramipexole (n=27) Levodopa+ropinirole (n=28) Control (n=25) P-value
LA diameter, mm 40.5±4.3 41.1±2.9 39.0±4.3 40.0±2.6 0.528b
LAVI (mL/m2) 26.4±1.5 26.4±1.57 25.7±1.29 25.8±1.6 0.090b
LVEDD (mm) 45.1±1.3 45.3±2.0 44.9±1.8 44.6±1.7 0.425b
LVESD (mm) 28.0±0.13 27.8±0.10 27.6±0.11 27.5±0.15 0.414b
PASP (mm Hg) 30.0 (27-33) 27.5 (26-32) 25.0 (26.5-28) 26.5 (25-35) 0.300a
EF (%) 53.7±3.7 53.4±5.3 54.4±2.1 54.5±4.3 0.407b
Diastolic filling pattern
Normal pattern 20 (55.6%) 19 (70.4%) 20 (71.4%) 19 (69.8%)
Grade 1 14 (38.9%) 7 (25.9%) 7 (25%) 8 (26%) 0.689c
Grade 2 2 (5.6%) 1 (3.7%) 1 (3.6%) 2 (5.1%)
Grade 3 0 0 0 0
E/Elateral 9.1±3.0 10.5±3.8 8.8±3.0 8.9±2.8 0.504b
S lateral (cm/s) 6.0 (5.5-8) 6.0 (5.4-7.5) 7.0 (5.8-8) 7.0 (5-10) 0.448a
a

Kruskal-Wallis test.

b

One-way analysis of variance.

c

Chi-square test.

E - early diastolic transmitral flow; Elateral′ - early diastolic lateral mitral annulus velocity; EF - ejection fraction; LA - left atrium; LAVI - left atrium volume index; LVEDD - left ventricular end-diastolic diameter; LVESD - left ventricular end-systolic diameter; PASP - pulmonary arterial systolic pressure; S - lateral systolic flow velocity